MRI-targeted biopsy: attractive and reliable diagnostic strategy for prostate cancer
November 2019

Two great papers, recently published in European Urology, confirm that MRI-targeted biopsy is the attractive and reliable diagnostic strategy for prostate cancer compared to the traditional diagnostic pathway of systematic TRUS biopsy:

  • an in-depth systematic review and meta-analysis from Veeru Kasivisvanathan et al. summarized only in one image:

  • as well as impressive results of a 2-year follow-up of systematic biopsy versus MRI and targeted and systematic biopsy (the randomized ASIST trial) from the Laurence Klotz group, summarized only in one image:

 

Read more in European Urology:
https://www.europeanurology.com/article/S0302-2838(19)30360-4/fulltext
https://www.europeanurology.com/article/S0302-2838(19)30773-0/fulltext

Back to main Go to news
This site uses cookies to improve your user experience. You may find out more about in our Privacy Policy. By using this website you accept our use of cookies.
OK